The prognostic value of PD-1 expression on CD4+ T cells in the peripheral blood of patients with NSCLC is evident and shows that high PD-1 expression is associated with poor clinical outcomes (135). The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.